Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A LINDEMANN

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Onkologie|June 1, 1989
[Mechanism of resistance to tumor necrosis factor]M Pfreundschuh, B Genth, H Kirchner, et al.
Analytical and Quantitative Cytology and Histology|April 1, 1995
DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myelomaE Leo, M Kropff, A Lindemann, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Cytokine gene transfer in cancer therapyL Cao, P Kulmburg, H Veelken, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1 beta secretion by IFN gamma and IL-2F Herrmann, S A Cannistra, A Lindemann, et al.
Blood|May 15, 1990
Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alphaN A Cicco, A Lindemann, J Content, et al.
Oncology|July 1, 1997
Dacarbazine and interferon alpha for stage IV malignant melanomaI Tamm, H Grimme, E Bergen, et al.
Annals of Hematology|October 1, 1991
Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisoloneF Herrmann, A Lindemann, W Lange, et al.
Biotechnology Therapeutics|January 1, 1991
Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndromeF Herrmann, R Mertelsmann, A Lindemann, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 12, 2018
Characterizing Functional Health Status of Surgical Patients in Clinical NotesSteven J Skube, Elizabeth A Lindemann, Elliot G Arsoniadis, et al.
The Journal of Clinical Investigation|August 1, 1989
Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth controlW Oster, N A Cicco, H Klein, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Onkologie|June 1, 1989
[Mechanism of resistance to tumor necrosis factor]M Pfreundschuh, B Genth, H Kirchner, et al.
Analytical and Quantitative Cytology and Histology|April 1, 1995
DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myelomaE Leo, M Kropff, A Lindemann, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Cytokine gene transfer in cancer therapyL Cao, P Kulmburg, H Veelken, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1 beta secretion by IFN gamma and IL-2F Herrmann, S A Cannistra, A Lindemann, et al.
Blood|May 15, 1990
Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alphaN A Cicco, A Lindemann, J Content, et al.
Oncology|July 1, 1997
Dacarbazine and interferon alpha for stage IV malignant melanomaI Tamm, H Grimme, E Bergen, et al.
Annals of Hematology|October 1, 1991
Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisoloneF Herrmann, A Lindemann, W Lange, et al.
Biotechnology Therapeutics|January 1, 1991
Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndromeF Herrmann, R Mertelsmann, A Lindemann, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 12, 2018
Characterizing Functional Health Status of Surgical Patients in Clinical NotesSteven J Skube, Elizabeth A Lindemann, Elliot G Arsoniadis, et al.
The Journal of Clinical Investigation|August 1, 1989
Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth controlW Oster, N A Cicco, H Klein, et al.
Pageof 17